ArticleJournal of pathology informatics2026
Lessons learned from the validation of a machine learning-based colorectal carcinoma screening pipeline in sub-Saharan Africa.
Article in Journal of pathology informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Background: Artificial intelligence for digital pathology may improve cancer detection and workflow efficiency in low- and middle-income countries, but most models are trained and validated in high-income settings, creating uncertainty about generalizability and real-world deployability under differing pre-analytic and infrastructure conditions. Objective: To validate a locally optimized colorectal carcinoma screening pipeline, retrained on data from a local Kenyan cohort, and to assess its feasibility as a sensitivity-forward assistive pre-screening workflow. Methods: Formalin-fixed, paraffin-embedded hematoxylin and eosin-stained slides from 136 biopsy-proven colonic adenocarcinoma cases and 20 normal controls from 2 Kenyan institutions were digitized at 40× using a Grundium Ocus scanner. Whole-slide images were partitioned at the case level. A feature-enrichment and candidate tile-selection step identified adenocarcinoma-rich regions. Candidate 512 × 512 RGB tiles were then adjudicated by a gastrointestinal pathologist into adenocarcinoma-containing and benign/non-neoplastic tile libraries. These expert-curated tiles were used to train and validate a supervised convolutional neural network classifier, which generated tile-level malignancy probabilities. Tile scores were aggregated into case-level predictions using Top-K pooling and positive-tile burden rules to support sensitivity-forward screening. Results: Among 14,452 tiles from 70 quality-controlled cases and 19 controls, the model achieved strong tile-level discrimination (sensitivity 0.9548, specificity 0.9926, F1 score 0.9686, and AUROC curve 0.966); case-level Top-K aggregation achieved an AUROC of 1.0. Conclusion: A locally optimized computational pathology screening pipeline, based on data from a local population, demonstrated robust colorectal adenocarcinoma detection in a Kenyan cohort. These findings suggest that existing machine-learning models can be adapted to local populations through retraining with locally derived data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.